XM does not provide services to residents of the United States of America.

Indian shares drop as investors sell on profit; Infosys gains



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares drop as investors sell on profit; Infosys gains</title></head><body>

Updates at 10:35 a.m. IST

By Manvi Pant and Bharath Rajeswaran

BENGALURU, July 19 (Reuters) -Indian shares reversed gains after rising to record highs at the open on Friday as broad-based profit booking outweighed results-driven gainsin heavyweight InfosysINFY.NS.

The NSE Nifty 50 .NSEI and the S&P BSE Sensex .BSESN rose about 0.3% each to hit record high levels at the open, before turning about 0.35% lower as of 10:35 a.m.IST.

Eleven of the 13 major sectors logged losses. The broader, more domestically focussed small- .NIFSMCP100 and mid-caps .NIFMDCP100 fell about 1.5%each.

"At record high levels, bouts of ... profit booking are likely, especially ahead of the national budget," said Siddhartha Khemka, vice president, head of research (retail) at Motilal Oswal Financial Services.

Other analystsexpect the government to announce measures to boost consumption, while maintaining its adherence to fiscal prudence, helped by record high dividend from the Reserve Bank of India and tax buoyancy.

IT stocks .NIFTYIT gained .NIFTYIT 0.7%, led by a 3% rise in Infosys.

India's second-largest IT services firm on Thursday raised its fiscal year 2025 revenue growth outlook to 3%-4% from 1%-3%, helped by demand recovery.

IT firm Persistent Systems PERS.NS lost 5% after reporting operating profit margins below analysts' estimates.

Oil-to-telecom conglomerate Reliance Industries RELI.NS, the second heaviest stock in the Nifty 50 index dropped 1% ahead of reporting its quarterly results, post closing bell on Friday.

Drug maker Zydus Lifesciences ZYDU.NS lost 3% after the U.S. drug regulator said it foundobjectionable conditions at its Gujarat facility, indicating regulatory sanctions.



Reporting by Manvi Pant and Bharath Rajeshwaran in Bengaluru; Editing by Varun H K, Sohini Goswami and Nivedita Bhattacharjee

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.